Clinical guides
Independent, sourced information about Mounjaro and weight management treatments in the UK. Reviewed by a GPhC-registered pharmacist.
Mounjaro vs Wegovy: a UK comparison
How tirzepatide (Mounjaro) and semaglutide (Wegovy) differ in mechanism, weight-loss data, side-effect profile and UK availability.
Read the guide →Mounjaro vs Ozempic: what's actually different
Ozempic is licensed for type 2 diabetes, not weight loss. Here is what that means in practice, and why Mounjaro is the licensed weight-management option.
Read the guide →How Mounjaro works: the science of GLP-1 and GIP
Mounjaro is the first dual GLP-1/GIP receptor agonist licensed in the UK. A plain-English explanation of what that means.
Read the guide →Mounjaro side effects: a UK clinical guide
A complete, SmPC-sourced list of Mounjaro side effects — common, less common and serious — with practical guidance on what to do about each.
Read the guide →